Literature DB >> 3710589

Primary murine immunoglobulin M responses to certain pneumococcal capsular polysaccharides consist primarily of anti-pneumococcal cell wall carbohydrate antibodies.

R L Fairchild, K E Sterner, H Braley-Mullen.   

Abstract

The antibody induced in mice immunized with a vaccine preparation of type 6 (Danish type 6A) pneumococcal capsular polysaccharide (S6) reacted with several chemically disparate pneumococcal capsular polysaccharides. Equivalent numbers of plaque-forming cells were observed when sheep erythrocytes coated with either S6, type 19 pneumococcal capsular polysaccharide (S19), or the pneumococcal cell wall carbohydrate (PnC) were used to detect the response to S6 or to S19. The addition of exogenous PnC to the plaquing mixtures of spleen cells from S6-, S19-, or PnC-immunized mice inhibited the appearance of most (greater than or equal to 85%) of the plaque-forming cells. Furthermore, the addition of monoclonal antibody specific for the dominant (TEPC 15) idiotype of anti-phosphorylcholine (a component of PnC) antibodies also inhibited the appearance of most of the plaque-forming cells. A suppressed S19 response was induced by priming mice with a low dose of S19 or PnC 3 days before immunization with an optimal dose of S19 (low-dose paralysis). These results demonstrated that most, if not all, of the antibody stimulated by these preparations of S6 and S19 was actually induced by and was specific for PnC.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3710589      PMCID: PMC260941          DOI: 10.1128/iai.52.3.867-871.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  Strain differences in the antibody plaque-forming cell responses of inbred mice to pneumococcal polysaccharide.

Authors:  H C Braley; M J Freeman
Journal:  Cell Immunol       Date:  1971-02       Impact factor: 4.868

2.  Direct evidence for the involvement of T suppressor cells in the expression of low-dose paralysis to type III pneumococcal polysaccharide.

Authors:  P J Baker; D F Amsbaugh; P W Stashak; G Caldes; B Prescott
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

3.  Characterization of antigen-specific immunologic paralysis induced by a single low dose of polyvinylpyrrolidone.

Authors:  J P Lake; N D Reed
Journal:  J Reticuloendothel Soc       Date:  1976-10

4.  Conversion of type III pneumococcal polysaccharide low responders to high responders by immunization with a thymus-dependent form of antigen.

Authors:  H Braley-Mullen; G C Sharp
Journal:  Cell Immunol       Date:  1974-04       Impact factor: 4.868

5.  Regulation of the antibody response to type 3 pneumococcal polysaccharide. IV. Role of suppressor T cells in the development of low-dose paralysis.

Authors:  P J Baker; P W Stashak; D F Amsbaugh; B Prescott
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

6.  Clonal nature of the immune response to phosphocholine. VII. Evidence throughout inbred mice for molecular similarities among antibodies bearing the T15 idiotype.

Authors:  J L Claflin; M Cubberley
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

7.  C-polysaccharide in a pneumococcal vaccine.

Authors:  U B Sørensen; J Henrichsen
Journal:  Acta Pathol Microbiol Immunol Scand C       Date:  1984-12

8.  Uniformity in the clonal repertoire for the immune response to phosphorylcholine in mice.

Authors:  J L Claflin
Journal:  Eur J Immunol       Date:  1976-10       Impact factor: 5.532

9.  Monoclonal vs. heterogeneous anti-H-8 antibodies in the analysis of the anti-phosphorylcholine response in BALB/c mice.

Authors:  J F Kearney; R Barletta; Z S Quan; J Quintáns
Journal:  Eur J Immunol       Date:  1981-11       Impact factor: 5.532

10.  Immunization of dissociated spleen cell cultures from normal mice.

Authors:  R I Mishell; R W Dutton
Journal:  J Exp Med       Date:  1967-09-01       Impact factor: 14.307

View more
  4 in total

1.  Induction of anti-pneumococcal cell wall polysaccharide antibodies by type 4 pneumococcal polysaccharide-protein conjugates.

Authors:  C Peeters; A M Tenbergen-Meekes; J Poolmann; B Zegers; G Rijkers
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

Review 2.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

3.  A thymus-independent (type 1) phosphorylcholine antigen isolated from Trichinella spiralis protects mice against pneumococcal infection.

Authors:  P L Lim; W F Choy
Journal:  Immunology       Date:  1990-03       Impact factor: 7.397

4.  Synthesis and physicochemical and immunological characterization of pneumococcus type 12F polysaccharide-diphtheria toxoid conjugates.

Authors:  A Fattom; W F Vann; S C Szu; A Sutton; X Li; D Bryla; G Schiffman; J B Robbins; R Schneerson
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.